The deterministic role of 5-mers in microRNA-gene targeting

References

• Lee TI, Young RA. Transcriptional regulation and its misregulation in disease. Cell. 2013;152:1237–51.
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–54.
   PubMed Web of Science ®Google Scholar
• Hofmann S, Huang Y, Paulicka P, et al. Double-Stranded Ligation Assay for the Rapid Multiplex Quantification of MicroRNAs. Anal Chem. 2015;87:12104–11.
   PubMed Web of Science ®Google Scholar
• Kappel A, Backes C, Huang Y, et al. MicroRNA in vitro diagnostics using immunoassay analyzers. Clin Chem. 2015;61:600–7.
   PubMed Web of Science ®Google Scholar
• Mestdagh P, Hartmann N, Baeriswyl L, et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods. 2014;11:809–15.
   PubMed Web of Science ®Google Scholar
• Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42:D68–73.
   PubMed Web of Science ®Google Scholar
• Yu SL, Chen HY, Chang GC, et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell. 2008;13:48–57.
   PubMed Web of Science ®Google Scholar
• Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449:682–8.
   PubMed Web of Science ®Google Scholar
• Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005;65:6029–33.
   PubMed Web of Science ®Google Scholar
• Meder B, Keller A, Vogel B, et al. MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol. 2011;106:13–23.
   PubMed Web of Science ®Google Scholar
• Keller A, Leidinger P, Borries A, et al. miRNAs in lung cancer – studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer. 2009;9:353.
   PubMed Web of Science ®Google Scholar
• Keller A, Leidinger P, Lange J, et al. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One. 2009;4:e7440.
   PubMed Web of Science ®Google Scholar
• Keller A, Leidinger P, Steinmeyer F, et al. Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Mult Scler. 2014;20:295–303.
   PubMed Web of Science ®Google Scholar
• Leidinger P, Keller A, Borries A, et al. High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer. 2010;10:262.
   PubMed Web of Science ®Google Scholar
• Hausler SF, Keller A, Chandran PA, et al. Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer. 2010;103:693–700.
   PubMed Web of Science ®Google Scholar
• Leidinger P, Keller A, Borries A, et al. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer. 2011;74:41–7.
   PubMed Web of Science ®Google Scholar
• Roth P, Wischhusen J, Happold C, et al. A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem. 2011;118:449–57.
   PubMed Web of Science ®Google Scholar
• Leidinger P, Backes C, Deutscher S, et al. A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol. 2013;14:R78.
   PubMed Web of Science ®Google Scholar
• Keller A, Leidinger P, Vogel B, et al. miRNAs can be generally associated with human pathologies as exemplified for miR-144. BMC Med. 2014;12:224.
   PubMed Web of Science ®Google Scholar
• Lee I, Ajay SS, Yook JI, et al. New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites. Genome Res. 2009;19:1175–83.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs.: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.
   PubMed Web of Science ®Google Scholar
• Almeida MI, Reis RM, Calin GA. MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res. 2011;717:1–8.
   PubMed Web of Science ®Google Scholar
• Reyes-Herrera PH, Ficarra E. One decade of development and evolution of microRNA target prediction algorithms. Genomics Proteomics Bioinformatics. 2012;10:254–63.
   PubMedGoogle Scholar
• Srivastava PK, Moturu TR, Pandey P, et al. A comparison of performance of plant miRNA target prediction tools and the characterization of features for genome-wide target prediction. BMC Genomics. 2014;15:348.
   PubMed Web of Science ®Google Scholar
• Peterson SM, Thompson JA, Ufkin ML, et al. Common features of microRNA target prediction tools. Front Genet. 2014;5:23.
   PubMed Web of Science ®Google Scholar
• Agarwal V, Bell GW, Nam JW, et al. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:
   Web of Science ®Google Scholar
• Reczko M, Maragkakis M, Alexiou P, et al. Functional microRNA targets in protein coding sequences. Bioinformatics. 2012;28:771–6.
   PubMed Web of Science ®Google Scholar
• Hamberg M, Backes C, Fehlmann T, et al. MiRTargetLink–miRNAs, Genes and Interaction Networks. Int J Mol Sci. 2016;17:564.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs.: target recognition and regulatory functions. Cell. 2009;136:215–33.
   PubMed Web of Science ®Google Scholar
• Brennecke J, Stark A, Russell RB, et al. Principles of microRNA-target recognition. PLoS Biol. 2005;3:e85.
   PubMed Web of Science ®Google Scholar
• Hart M, Rheinheimer S, Leidinger P, et al. Identification of miR-34a-target interactions by a combined network based and experimental approach. Oncotarget. 2016;7:34288–99.
   PubMedGoogle Scholar
• Ludwig N, Kim YJ, Mueller SC, et al. Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs. Neuro Oncol. 2015;17:1250–60.
   PubMed Web of Science ®Google Scholar
• Landi MT, Zhao Y, Rotunno M, et al. MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res. 2010;16:430–41.
   PubMed Web of Science ®Google Scholar
• Vogt M, Munding J, Gruner M, et al. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch. 2011;458:313–22.
   PubMed Web of Science ®Google Scholar
• Lodygin D, Tarasov V, Epanchintsev A, et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle. 2008;7:2591–600.
   PubMed Web of Science ®Google Scholar
• Siemens H, Neumann J, Jackstadt R, et al. Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and beta-catenin predicts distant metastasis of colon cancer. Clin Cancer Res. 2013;19:710–20.
   PubMed Web of Science ®Google Scholar
• Cui X, Zhao Z, Liu D, et al. Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma. J Exp Clin Cancer Res. 2014;33:20.
   PubMed Web of Science ®Google Scholar
• Xie K, Liu J, Chen J, et al. Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer. Gene. 2014;543:101–7.
   PubMed Web of Science ®Google Scholar
• Li Y, Guessous F, Zhang Y, et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009;69:7569–76.
   PubMed Web of Science ®Google Scholar
• He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network. Nature. 2007;447:1130–4.
   PubMed Web of Science ®Google Scholar
• Liu C, Kelnar K, Liu B, et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 2011;17:211–5.
   PubMed Web of Science ®Google Scholar
• Bu P, Chen KY, Chen JH, et al. A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. Cell Stem Cell. 2013;12:602–15.
   PubMed Web of Science ®Google Scholar
• Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A. 2008;105:13421–6.
   PubMed Web of Science ®Google Scholar
• Eichelser C, Flesch-Janys D, Chang-Claude J, et al. Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression. Clin Chem. 2013;59:1489–96.
   PubMed Web of Science ®Google Scholar
• Aherne ST, Madden SF, Hughes DJ, et al. Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression. BMC Cancer. 2015;15:329.
   PubMed Web of Science ®Google Scholar
• Franchina T, Amodeo V, Bronte G, et al. Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer. J Cell Physiol. 2014;229:97–9.
   PubMed Web of Science ®Google Scholar
• Baier G, Wagner J. PKC inhibitors: potential in T cell-dependent immune diseases. Curr Opin Cell Biol. 2009;21:262–7.
   PubMed Web of Science ®Google Scholar
• Huse M. Microtubule-organizing center polarity and the immunological synapse: protein kinase C and beyond. Front Immunol. 2012;3:235.
   PubMed Web of Science ®Google Scholar
• Quann EJ, Liu X, Altan-Bonnet G, et al. A cascade of protein kinase C isozymes promotes cytoskeletal polarization in T cells. Nat Immunol. 2011;12:647–54.
   PubMed Web of Science ®Google Scholar
• Grybko MJ, Pores-Fernando AT, Wurth GA, et al. Protein kinase C activity is required for cytotoxic T cell lytic granule exocytosis, but the theta isoform does not play a preferential role. J Leukoc Biol. 2007;81:509–19.
   PubMed Web of Science ®Google Scholar
• Wei SY, Lin TE, Wang WL, et al. Protein kinase C-delta and -beta coordinate flow-induced directionality and deformation of migratory human blood T-lymphocytes. J Mol Cell Biol. 2014;6:458–72.
   PubMed Web of Science ®Google Scholar
• Yates A, Akanni W, Amode MR, et al. Ensembl 2016. Nucleic Acids Res. 2016;44:D710–6.
   PubMed Web of Science ®Google Scholar
• Chou CH, Shrestha S, Yang CD, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2018;46:D296–D302.
   PubMed Web of Science ®Google Scholar
• Vergoulis T, Vlachos IS, Alexiou P, et al. TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res. 2012;40:D222–9.
   PubMed Web of Science ®Google Scholar
• Xiao F, Zuo Z, Cai G, et al. miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res. 2009;37:D105–10.
   PubMed Web of Science ®Google Scholar
• Helwak A, Kudla G, Dudnakova T, et al. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell. 2013;153:654–65.
   PubMed Web of Science ®Google Scholar
• Acuto O, Hussey RE, Fitzgerald KA, et al. The human T cell receptor: appearance in ontogeny and biochemical relationship of alpha and beta subunits on IL-2 dependent clones and T cell tumors. Cell. 1983;34:717–26.
   PubMed Web of Science ®Google Scholar
• Moran AE, Hogquist KA. T-cell receptor affinity in thymic development. Immunology. 2012;135:261–7.
   PubMed Web of Science ®Google Scholar
• Merkle PS, Irving M, Hongjian S, et al. The T-Cell Receptor Can Bind to the Peptide-Bound Major Histocompatibility Complex and Uncomplexed beta2-Microglobulin through Distinct Binding Sites. Biochemistry. 2017;56:3945–61.
   PubMed Web of Science ®Google Scholar
• Yaciuk JC, Pan Y, Schwarz K, et al. Defective selection of thymic regulatory T cells accompanies autoimmunity and pulmonary infiltrates in Tcra-deficient mice double transgenic for human La/Sjogren's syndrome-B and human La-specific TCR. J Immunol. 2015;194:1514–22.
   PubMed Web of Science ®Google Scholar
• Beitzinger M, Peters L, Zhu JY, et al. Identification of human microRNA targets from isolated argonaute protein complexes. RNA Biol. 2007;4:76–84.
   PubMed Web of Science ®Google Scholar
• Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841–2.
   PubMed Web of Science ®Google Scholar
• Langmead B, Trapnell C, Pop M, et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10:R25.
   PubMed Web of Science ®Google Scholar
• Li H, Handsaker B, Wysoker A, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–9.
   PubMed Web of Science ®Google Scholar